Jim Simons
ORGO icon

Jim Simons’s Organogenesis Holdings ORGO Stock Holding History

Jim Simons’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
1,017,113
-51,425
-5% -$126K ﹤0.01% 1847
2026
Q1 		$2.53M Buy
1,068,538
+249,838
+31% +$865K ﹤0.01% 1764
2025
Q4 		$4.24M Sell
818,700
-2,800
-0.3% -$13.6K 0.01% 1397
2025
Q3 		$3.47M Buy
821,500
+17,600
+2% +$81.8K ﹤0.01% 1700
2025
Q2 		$2.94M Sell
803,900
-239,600
-23% -$893K ﹤0.01% 1862
2025
Q1 		$4.51M Sell
1,043,500
-30,000
-3% -$121K 0.01% 1499
2024
Q4 		$3.44M Buy
1,073,500
+255,600
+31% +$858K 0.01% 1686
2024
Q3 		$2.34M Buy
817,900
+22,200
+3% +$62.3K ﹤0.01% 1914
2024
Q2 		$2.23M Sell
795,700
-11,400
-1% -$30.6K ﹤0.01% 1820
2024
Q1 		$2.29M Sell
807,100
-50,625
-6% -$172K ﹤0.01% 1942
2023
Q4 		$3.51M Buy
857,725
+173,631
+25% +$486K 0.01% 1573
2023
Q3 		$2.17M Sell
684,094
-22,008
-3% -$69.9K ﹤0.01% 1813
2023
Q2 		$2.34M Sell
706,102
-542,298
-43% -$1.6M ﹤0.01% 1893
2023
Q1 		$2.66M Buy
1,248,400
+75,002
+6% +$185K ﹤0.01% 1853
2022
Q4 		$3.16M Sell
1,173,398
-9,602
-0.8% -$28K ﹤0.01% 1784
2022
Q3 		$3.83M Buy
1,183,000
+710,800
+151% +$3.21M 0.01% 1600
2022
Q2 		$2.3M Buy
472,200
+126,400
+37% +$778K ﹤0.01% 2088
2022
Q1 		$2.63M Buy
345,800
+220,200
+175% +$1.7M ﹤0.01% 2016
2021
Q4 		$1.16M Sell
125,600
-244,000
-66% -$2.59M ﹤0.01% 2538
2021
Q3 		$5.26M Sell
369,600
-339,600
-48% -$5.27M 0.01% 1436
2021
Q2 		$11.8M Buy
709,200
+20,300
+3% +$378K 0.01% 1068
2021
Q1 		$12.6M Buy
688,900
+42,600
+7% +$577K 0.02% 1039
2020
Q4 		$4.87M Buy
646,300
+454,500
+237% +$2.16M 0.01% 1603
2020
Q3 		$737K Buy
191,800
+57,300
+43% +$226K ﹤0.01% 2663
2020
Q2 		$516K Buy
134,500
+66,900
+99% +$241K ﹤0.01% 2861
2020
Q1 		$218K Buy
67,600
+32,300
+92% +$138K ﹤0.01% 3081
2019
Q4 		$170K Buy
+35,300
New +$224K ﹤0.01% 3225

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jim Simons's ORGO Position: Q2 2026 in Review

Jim Simons reduced its Organogenesis Holdings (ORGO) stake by 4.8% in Q2 2026, selling an estimated $126K and leaving 1,017,113 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Jim Simons first reported a position in ORGO in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.6M in Q1 2021. 89 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Jim Simons held 1,017,113 shares of Organogenesis Holdings worth $2.47M as of Q2 2026.
  • Jim Simons sold 51,425 Organogenesis Holdings shares in Q2 2026, an estimated $126K.
  • Organogenesis Holdings made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #1847 holding.
  • Jim Simons first reported a position in Organogenesis Holdings in Q4 2019 and has held it in 27 quarters since.
  • Jim Simons's Organogenesis Holdings position peaked at $12.6M in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.